PROTEON THERAPEUTICS INC - COM (PRTO)

CUSIP: 74371L109

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
8,173,950
Share change
-50,046
Total reported value
$75,818,000
Price per share
$9.33
Number of holders
29
Value change
-$324,409
Number of buys
9
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 74371L109?
CUSIP 74371L109 identifies PRTO - PROTEON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTEON THERAPEUTICS INC - COM (PRTO) as of Q3 2016

As of 30 Sep 2016, PROTEON THERAPEUTICS INC - COM (PRTO) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,173,950 shares. The largest 10 holders included Abingworth LLP, RA CAPITAL MANAGEMENT, LLC, DEERFIELD MANAGEMENT CO, MPM ASSET MANAGEMENT LLC, Deer VII & Co. Ltd., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, Omega Fund Management, LLC, PRINCIPAL FINANCIAL GROUP INC, and TIVERTON ASSET MANAGEMENT LLC. This page lists 29 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.